Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 182

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Serum Levels of Insulin-Like Growth Factor I in 152 Patients with Growth Hormone Deficiency, Aged 19–82 Years, in Relation to Those in Healthy Subjects1

Hilding, Agneta, Hall, Kerstin, Wivall-Helleryd, Inga-Lena, Sääf, Maria, Melin, Anna-Lisa, Thorén, Marja·1999·The Journal of Clinical Endocrinology & Metabolism

Abstract

Serum insulin-like growth factor I (IGF-I) levels within normal range for age have been reported to be common in adults with GH deficiency (GHD). Therefore, serum IGF-I levels were determined in 152 consecutive patients (71 women and 81 men) with evidence of hypothalamic-pituitary disorders or previous cranial radiation, who fulfilled the presently used criteria for GHD i.e. peak GH response below 3μ g/L at stimulation test. Patients treated for acromegaly were excluded. Forty-three patients, aged 19–63 yr, had childhood onset GHD, and 109, aged 23–82 yr, had adult-onset GHD. Their IGF-I levels were expressed in sd scores in relation to normal reference values based on 448 healthy subjects, aged 20–96 yr (247 women and 201 men). In healthy subjects a linear inverse correlation, without gender difference, was found between logarithmic transformed IGF-I levels and age (r = −0.774; P < 0.001). In contrast, no age dependency was found in GHD patients. All patients with childhood-onset GHD had IGF-I values below −2 sd, significantly lower than those in adult-onset GHD patients (−6.2± 0.3 vs. −3.2 ± 0.2 sd score; P < 0.001). In patients with adult-onset GHD, 34% of the IGF-I levels were within normal range, increasing to 40% in the subgroup above 60 yr of age, in whom 86% were diagnosed with hypothalamic-pituitary tumors. Normal IGF-I was more common in men than in women, but no difference was observed between patients with panhypopituitarism and those with partial pituitary insufficiency. High frequencies of IGF-I levels within the normal range were found in GHD patients with pituitary tumors (20 of 57 nonsecreting pituitary adenomas, 5 of 15 prolactinomas, 6 of 12 Cushing’s disease, and 4 of 25 craniopharyngiomas), but in only 2 of 43 patients with GHD due to other causes. In conclusion, an IGF-I level below −2 sd seems to be of diagnostic value in GHD with onset in childhood or early adulthood, whereas values within normal range are common in patients over 60 yr of age, especially those with pituitary tumors. The outcome of GH replacement therapy may reveal whether the addition of IGF-I as a diagnostic criterion is of predictive value in older patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jcem.84.6.5793

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 30

  1. De Boer,, 1995, Clinical aspects of growth hormone deficiency in adults., Endocr Rev, 16, 63, 10.1210/er.16.1.63 · DOI
  2. Attanasio, 1997, Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment., J Clin Endocrinol Metab, 82, 82
  3. Bates, 1995, Assessmant of GH status in adults wtih GH deficiency using serum growth hormone, serum insulin-like growth factor-I and urinary growth hormone excretion., Clin Endocrinol (Oxf), 42, 425, 10.1111/j.1365-2265.1995.tb02652.x · DOI
  4. Thissen, 1996, Use of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in the diagnosis of acromegaly and growth hormone deficiency in adults., Growth Regul, 6, 222
  5. Svensson, 1997, Insulin-like growth factor-I in growth hormone-deficient adults: relationship to population-based normal values, body composition and insulin tolerance test., Clin Endocrinol (Oxf), 46, 579, 10.1046/j.1365-2265.1997.1851001.x · DOI
  6. Shalet, 1998, The diagnosis of growth hormone deficiency in children and adults., Endocr Rev, 19, 203, 10.1210/edrv.19.2.0329 · DOI · Paper page
  7. Hilding, 1995, Altered relation between circulating levels of insulin-like growth factor binding protein-1 and insulin in growth hormone deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects., J Clin Endocrinol Metab, 80, 2646
  8. 1998, Consensus guidelines for diagnosis and treatment of adults with GH deficiency: summary statement of Growth Hormone Research Society Workshop on adult growth hormone deficiency., J Clin Endocrinol Metab, 83, 379
  9. Kowarski, 1971, Determination of integrated plasma concentrations and true secretion rates of human growth hormone., J Clin Endocrinol Metab, 32, 356, 10.1210/jcem-32-3-356 · DOI · Paper page
  10. Bang, 1991, Comparison of acid ethanol extraction and gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by use of truncated IGF-I as radioligand., Acta Endocrinol (Copenh), 124, 620, 10.1530/acta.0.1240620 · DOI · Paper page
  11. Luthman, 1990, Monoclonal antibodies reveal circulating growth hormone of high molecular weight not detectable with conventional assays., Acta Endocrinol (Copenh), 123, 317, 10.1530/acta.0.1230317 · doi:10.1530/acta.0.1230317
  12. Rudman, 1981, Impaired growth hormone secretion in the adult population: relation to age and adiposity., J Clin Invest, 67, 1361, 10.1172/JCI110164 · DOI · Paper page
  13. Florini, 1985, Somatomedin-C levels in healthy young and old men: relationship to peak and 24-hour integrated levels of growth hormone., J Gerontol, 40, 2, 10.1093/geronj/40.1.2 · DOI · Paper page
  14. 1987, Nyctohermal growth hormone profiles in young and aged men: correlation with somatomedin-C levels., J Clin Endocrinol Metab, 64, 884, 10.1210/jcem-64-5-884 · DOI · Paper page
  15. Jørgensen, 1990, Evening vs. morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites., J Clin Endocrinol Metab, 70, 207, 10.1210/jcem-70-1-207 · DOI
  16. Toogood, 1996, Beyond the somatopause: growth hormone deficiency in adults over the age of 60 years., J Clin Endocrinol Metab, 81, 460
  17. Olivecrona, 1999, Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messanger ribonucleic acid responses in humans., J Clin Endocrinol Metab, 84, 553
  18. Juul, 1998, The acid-labile subunit of human ternary insulin-like growth factor binding protein complex in serum: hepatosplanchnic release, diurnal variation, circulating concentrations in healthy subjects, and diagnostic use in patients with growth hormone deficiency., J Clin Endocrinol Metab, 83, 4408, 10.1210/jcem.83.12.5311 · doi:10.1210/jcem.83.12.5311
  19. Thorén, 1997, Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and −3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency., J Clin Endocrinol Metab, 82, 223
  20. Thorén, 1998, Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and −5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy., J Bone Miner Res, 13, 891, 10.1359/jbmr.1998.13.5.891 · DOI
  21. Tassoni, 1990, Variability of growth hormone response to pharmacological and sleep tests performed twice in short children., J Clin Endocrinol Metab, 71, 230, 10.1210/jcem-71-1-230 · DOI
  22. Hoeck, 1995, Test of growth hormone secretion in adults: poor reproducibility of the insulin tolerance test., Eur J Endocrinol, 133, 305, 10.1530/eje.0.1330305 · DOI
  23. Kelly, 1991, The prolactin/growth hormone receptor family., Endocr Rev, 12, 235, 10.1210/edrv-12-3-235 · DOI · Paper page
  24. De Boer, 1994, Diagnosis of growth hormone deficiency in adults[ Letter]., Lancet, 343, 1645, 10.1016/S0140-6736(94)93104-6 · DOI
  25. Yamamoto, 1991, Effects of aging and sex on plasma insulin-like growth factor I (IGF-I) levles in normal adults., Acta Endocrinol (Copenh), 124, 497, 10.1530/acta.0.1240497 · DOI
  26. Landin-Wilhelmsson, 1994, Serum insulin-like growth factor I in a random population of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin., Clin Endocrinol (Oxf), 41, 351, 10.1111/j.1365-2265.1994.tb02556.x · DOI · Paper page
  27. Juul, 1994, The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients., Clin Endocrinol (Oxf), 41, 85, 10.1111/j.1365-2265.1994.tb03788.x · DOI · Paper page
  28. Kitano, 1995, Serum insulin-like growth factor-I (IGF-I) in normal Japanese adults., Endocr J, 42, 767, 10.1507/endocrj.42.767 · DOI
  29. Nyström, 1997, Population-based reference values for IGF-I and IGF-binding protein-1:relations with metabolic and anthropometric variables., Eur J Endocrinol, 136, 165, 10.1530/eje.0.1360165 · DOI
  30. Thissen, 1994, Nutritional regulation of insulin-like growth factors., Endocr Rev, 15, 80

Cited by

See all 182

Metadata

Authors
Hilding, A., Hall, K., Wivall-Helleryd, I.-L., Sääf, M., Melin, A.-L., & Thorén, M.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1999-06-01
Volume
84
Issue
6
Pages
2013-2019
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2066244030
Cited by
182
References
2
FWCI
4.89
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum Levels of Insulin-Like Growth Factor I in 152 Patients with Growth Hormone Deficiency, Aged 19–82 Years, in Relation to Those in Healthy Subjects1. https://app.cochat.ai/papers/10.1210/jcem.84.6.5793
The paper
Hilding, A., Hall, K., Wivall-Helleryd, I.-L., Sääf, M., Melin, A.-L., & Thorén, M. (1999). Serum Levels of Insulin-Like Growth Factor I in 152 Patients with Growth Hormone Deficiency, Aged 19–82 Years, in Relation to Those in Healthy Subjects1. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem.84.6.5793

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.